National Health Investors, Inc. (NHI)

National Health Investors Stock Forecast

Stock Price Forecast

The 5 analysts that cover National Health Investors stock have a consensus rating of "Buy" and an average price target of $87, which forecasts a 5.69% increase in the stock price over the next year. The lowest target is $80 and the highest is $92.

Price Target: $87 (+5.69%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$80	$87	$88	$92
Change	-2.82%	+5.69%	+6.90%	+11.76%

Analyst Ratings

The average analyst rating for National Health Investors stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Oct '25	Nov '25	Dec '25	Jan '26	Feb '26	Mar '26
Strong Buy	1	1	1	1	1	1
Buy	2	2	3	3	3	3
Hold	1	1	1	1	1	1
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	4	4	5	5	5	5

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Michael Lewis Truist Securities	Truist Securities	Strong Buy Maintains $85 → $92	Strong Buy	Maintains	$85 → $92	+11.76%	Mar 12, 2026
Michael Lewis Truist Securities	Truist Securities	Strong Buy Maintains $81 → $83	Strong Buy	Maintains	$81 → $83	+0.83%	Dec 16, 2025
Todd M. Thomas Keybanc	Keybanc	Buy Maintains $80 → $88	Buy	Maintains	$80 → $88	+6.90%	Dec 4, 2025
John Kilichowski Wells Fargo	Wells Fargo	Hold Maintains $80 → $85	Hold	Maintains	$80 → $85	+3.26%	Nov 25, 2025
Richard Anderson Cantor Fitzgerald	Cantor Fitzgerald	Buy Initiates $90	Buy	Initiates	$90	+9.33%	Oct 1, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

417.66M

Increased by 10.12%

from 379.29M

Revenue Next Year

449.61M

Increased by 7.65%

from 417.66M

EPS This Year

3.37

Increased by 11.53%

from 3.02

EPS Next Year

3.44

Increased by 2.25%

from 3.37

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	297.17M	278.76M	320.39M	335.58M	379.29M	417.66M	449.61M
Revenue Growth	-9.86%	-6.19%	14.93%	4.74%	13.03%	10.12%	7.65%
EPS	2.44	1.48	3.13	3.13	3.02	3.37	3.44
EPS Growth	-41.06%	-39.34%	111.16%	0.16%	-3.51%	11.53%	2.25%
Forward PE	-	-	-	-	-	24.44	23.90
No. Analysts	-	-	-	-	-	6	4

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2027	2028	2029	2030
High	452.5M	482.7M
Avg	417.7M	449.6M
Low	388.2M	422.0M

Revenue Growth

Revenue Growth	2026	2027	2028	2029	2030
High	19.3%	15.6%
Avg	10.1%	7.6%
Low	2.3%	1.0%

EPS Forecast

EPS	2026	2027	2028
High	3.68	3.68
Avg	3.37	3.44
Low	3.15	3.25

EPS Growth

EPS Growth	2026	2027	2028
High	21.7%	9.1%
Avg	11.5%	2.2%
Low	4.2%	-3.4%

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.